Cebranopadol

Trial identifier (Sponsor):  KF6005/08
Trade name:  --
INN / Sponsor substance code:  Cebranopadol
Trial title: 

Efficacy, safety and tolerability of multiple doses of oral cebranopadol in subjects with moderate to severe chronic pain due to diabetic peripheral neuropathy

Brief title:  Comparison of cebranopadol with placebo and with pregabalin
Trial indication:  Moderate to severe chronic pain due to DPN
Trial status:  Completed
Results posted:  Yes (Eudra CT)
PubMed unique identifier [PMID]:  --
First subject enrolled:  27 Sep 2013
Last subject completed:  28 Jan 2015
UTN (WHO):  U1111-1151-4331
ClinicalTrials.gov identifier:  NCT01939366
Eudra CT identifier:  2013-000473-68
Available for data sharing:  No
Trial phase:  2

Back